Table 1.
Sample characteristics.
| Participant number | Age | IQ | ADOS Score | Comorbid symptoms | Neuroactive medications | Response to cTBS |
|---|---|---|---|---|---|---|
| 1 | 11 | 100 | 13 | Anxiety | Citalopram | Suppression |
| 2 | 9 | 94 | 7 | None | None | Facilitation |
| 3 | 12 | 86 | 10 | Anxiety, Inattention | Citalopram, atomoxetine | Suppression |
| 4 | 9 | 87 | 9 | Anxiety ADHD | None | Suppression |
| 5 | 14 | 115 | 8 | Anxiety, ADHD | Citalopram, atomoxetine | Facilitation |
| 6 | 14 | 99 | 9 | None | None | Facilitation |
| 7 | 10 | 106 | 12 | None | None | Suppression |
| 8 | 9 | 88 | 7 | None | None | Facilitation |
| 9 | 10 | 89 | 10 | ADHD | Buspirone | Suppression |
| 10 | 11 | 93 | 9 | Obsessive-Compulsive Behaviors, Anxiety | Sertraline, citalopram | Facilitation |
| 11 | 11 | 115 | 7 | ADHD | Methylphenidate | Suppression |
| 12 | 13 | 129 | 9 | Inattention | Atomoxetine | Suppression |
| 13 | 14 | 115 | 8 | ADHD | Atomoxetine | Suppression |
| 14 | 10 | 102 | 7 | Irritability | Risperidone | Suppression |
| 15 | 11 | 103 | 14 | Inattention | Guanfacine, methylphenidate | Facilitation |
| 16 | 13 | 102 | 7 | ADHD | Methylphenidate | Facilitation |
| 17 | 18 | 121 | 12 | None | None | Suppression |
| 18 | 18 | 83 | 13 | None | None | Suppression |
| 19 | 17 | 81 | 13 | None | None | Suppression |
| AVERAGE | 12.26 | 100.42 | 9.58 |